Friday, March 24, 2017 11:19:32 AM
LOS ANGELES, Calif. (May 12, 2016)
--
ViaDerma, a Los Angeles-based pharmaceutical firm has recently signed a deal with Coast to Coast Podiatry of Reseda to license its products. According to Dr. Chris Otiko, CEO of ViaDerma, the partnership will be beneficial to both companies. “ViaDerma will get our new products in front of patients who need them. And Coast to Coast will have cutting-edge medicine to help their patients in recovery,” he said. ViaDerma, Inc. produces TetraStem, a wound care drug that can also treats diabetic foot sores, acne and fight Methicillin-resistant Staphylococcus aureus (MRSA)infections.
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM